College of Pharmacy researcher investigating COVID-19 vaccine

1081
Martin D'Souza in his lab

Mercer University College of Pharmacy faculty member Martin D’Souza, Ph.D., recently began research into designing a microparticle vaccine for COVID-19.

Dr. D’Souza has previously used patented nanotechnology to design and deliver nanovaccines for infectious diseases and cancer. His approach involves using tiny “bead-like” nanoparticles and microparticles to deliver drugs and vaccines.

“The advantage of putting a vaccine in a microparticle is that it looks even more foreign to the body,” said Dr. D’Souza. “Therefore, the body creates an even stronger immune response.”

Continue reading about D’Souza’s work on a COVID-19 vaccine at news.mercer.edu.

 

Do you have a story idea or viewpoint you'd like to share with The Den?
Get in touch with us by emailing den@mercer.edu or submitting this online form.